Publication | Closed Access

Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopy

Biomarker (Medicine)UrologyEngineeringCancer DetectionMedicineSpectroscopyMass SpectrometryLocalized Proton SpectroscopyBenign Prostatic HyperplasiaClinical ChemistryProstatic DiseaseMolecular DiagnosticsMolecular ImagingNuclear MedicineRadiology